[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Bio_youtuber Biostock_Youtuber
Biostock_Youtuber posts on X about $bbio, $zlab, investment, $bmy the most. They currently have XXXXX followers and X posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Month XXXXX +265,500%
- X Months XXXXXX -XX%
Mentions: X #
- X Months XX -XX%
Followers: XXXXX #
- X Week XXXXX +6.80%
- X Month XXXXX +6.80%
- X Months XXXXX +34%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence finance XX% stocks XX% countries XX%
Social topic influence $bbio #5, $zlab #2, investment 25%, $bmy 25%, $15b 25%, china XX%
Top accounts mentioned or mentioned by @biotech2k
Top assets mentioned BridgeBio Pharma, Inc. Common Stock (BBIO) Bristol-Myers Squibb Co (BMY)
Top Social Posts #
Top posts by engagements in the last XX hours
"$BBIO + New I've been away from the market for a while due to a busy schedule but my investment in $BBIO has grown significantly. If the stock reaches the $8090 range I plan to sell about 2530% and hold the rest long term. In the meantime Ive been looking for my next opportunity. Over the weekend I did deeper research on a biotech stock from Biotech2ks list that fits my style limited downside risk but multi-bagger potential. I already built a small position and after this research my conviction has grown stronger. Im planning to buy more tomorrow. I believe that $BBIO and this new name will"
X Link @Bio_youtuber 2025-11-03T00:54Z 1058 followers, 1790 engagements
"$BMY Bristol-Myers Squibb quietly dropped two R&D programs Miratis SOS1 inhibitor (MRTX0902) and Exscientias PKC-theta inhibitor (EXS4318). Both were early-stage assets. This move aligns with BMSs $1.5B cost-cut plan and a clear shift under new CMO Cristian Massacesi toward high-value late-stage assets like the schizophrenia drug Cobenfy (14 ongoing/pivotal"
X Link @Bio_youtuber 2025-11-03T11:07Z 1058 followers, XXX engagements
"$ZLAB Ive built a sizable position in $ZLAB my second major holding after $BBIO. Most of Zais current valuation can be rationalized by its in-licensed assets which are high-quality. I expect the company to continue securing strong global partnerships. The DLL3-targeting ADC (ZL-1310-001) is particularly compelling: its efficacy looks roughly comparable to competitors but the safety profile appears differentiated likely due to payload linker design. Huge thanks to @Biotech2k for the consistently great insights"
X Link @Bio_youtuber 2025-11-03T21:22Z 1058 followers, XXX engagements
"$BBIO $ZLAB BMSs Cobenfy (KarXT) feels like a slower ramp so far. Zai Lab has licensed it for Greater China and plans to launch soon hopefully it will gain strong traction there. By contrast BBIOs ATTRuby though in a completely different disease area is showing a much stronger trajectory"
X Link @Bio_youtuber 2025-11-04T02:07Z 1058 followers, XXX engagements